The ACR Government Affairs Committee has developed legislative language to limit commercial insurance plans’ cost-sharing requirements for medications in a specialty drug tier to the dollar amount applicable to drugs in the nonpreferred-brand drug tier.
Coding Corner Question: August Coding Challenge
A 43-year-old female established patient diagnosed with rheumatoid arthritis comes to the office for her first infliximab infusion.
Coding Corner Answer: August Coding Challenge
A 43-year-old female established patient diagnosed with rheumatoid arthritis comes to the office for her first infliximab infusion.
Managing an In-Office Infusion Practice
The increased utilization of infusible biologics for the treatment of rheumatic diseases has opened the door for you to provide more integrated care for your patients. Having an in-office infusion center gives you the ability to deliver this service to your patients in a familiar and supportive setting.
EULAR 2012: Systemic Sclerosis That Doesn’t Fit the Mold
This disease presents a range of hard-to-solve clinical difficulties.
EULAR 2012: Does Arthritis Start in the Gut?
New research on the ties between bacteria and inflammatory disease.
Where the Presidential Candidates Stand on Key Healthcare Issues
Where President Obama and and Republican presidential candidate Mitt Romney stand on healthcare issues affecting rheumatologists and the medical profession as a whole.
Educational Leader Honored with Top Rheumatology Award
Paul Emery, MA, MD, receives prestigious Nachman Prize.
Patient Access to Medical Records: How Much Is Too Much?
The easy access to medical records stemming from technological advances has given rise to questions about the medical benefits to such easy access, questions now being explored by researchers in the U.S. and Europe.
Drug Updates: EULAR 2012
Tracking the results of drug safety and efficacy
- « Previous Page
- 1
- …
- 682
- 683
- 684
- 685
- 686
- …
- 820
- Next Page »